A double-blind placebo-controlled, randomised study comparing gemcitabine and marimastat with gemcitabine and placebo as first line therapy in patients with advanced pancreatic cancer-Reference-Cited by-同舟云学术

A double-blind placebo-controlled, randomised study comparing gemcitabine and marimastat with gemcitabine and placebo as first line therapy in patients with advanced pancreatic cancer

Published:2002-07 Issue:2 Volume:87 Page:161-167
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Bramhall S R,Schulz J,Nemunaitis J,Brown P D,Baillet M,Buckels J A C

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/6600446.pdf

Reference36 articles.

1. Bailey AJ, Parmar MK, Stephens RJ (1998) Patient-reported short-term and long-term physical and psychologic symptoms: results of the continuous hyperfractionated accelerated (correction of acclerated) radiotherapy (CHART) randomized trial in non-small-cell lung cancer. CHART Steering Committee. J Clin Oncol 16: 3082–3093

2. Bramhall SR, Allum WH, Jones AG, Allwood A, Cummins C, Neoptolemos JP (1995) Incidence, treatment and survival in 13,560 patients with pancreatic cancer: An epidemiological study in the West Midlands. Br J Surg 82: 111–115

3. Bramhall SR, Hallissey MT, Whiting J, Scholefield J, Tierney G, Stuart RC, Hawkins RE, McCulloch P, Maughan T, Brown PD, Baillet M, Fielding JWL (2001a) Marimastat as maintenance therapy for patients with advanced gastric and gastro-oesophageal cancer: A randomized trial. Br J Cancer (in press)

4. Bramhall SR, Neoptolemos JP (1997) Adjuvant chemotherapy in pancreatic cancer. Int J Pancreatol 21: 59–63

5. Bramhall SR, Neoptolemos JP, Stamp GW, Lemoine NR (1997) Imbalance of expression of matrix metalloproteinases (MMPs) and tissue inhibitors of the matrix metalloproteinases (TIMPs) in human pancreatic carcinoma. J Pathol 182: 347–355

Cited by 488 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New avenues for the treatment of immunotherapy-resistant pancreatic cancer;World Journal of Gastrointestinal Oncology;2024-04-15

2. Long-term outcomes of combined treatment of primary resectable pancreatic head cancer in patients over 70 years;Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery;2024-03-15

3. The extracellular matrix as hallmark of cancer and metastasis: From biomechanics to therapeutic targets;Science Translational Medicine;2024-01-03

4. Trajectories of immune-related serum proteins and quality of life in patients with pancreatic and other periampullary cancer: the CHAMP study;BMC Cancer;2023-11-07

5. Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group;Journal of Clinical Oncology;2023-10-20